BE813251A - PROCESS FOR PROLONGING THE EFFECT OF PHARMACEUTICAL COMPOUNDS - Google Patents
PROCESS FOR PROLONGING THE EFFECT OF PHARMACEUTICAL COMPOUNDSInfo
- Publication number
- BE813251A BE813251A BE142809A BE142809A BE813251A BE 813251 A BE813251 A BE 813251A BE 142809 A BE142809 A BE 142809A BE 142809 A BE142809 A BE 142809A BE 813251 A BE813251 A BE 813251A
- Authority
- BE
- Belgium
- Prior art keywords
- prolonging
- effect
- pharmaceutical compounds
- pharmaceutical
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22595/73A IT1053718B (en) | 1973-04-04 | 1973-04-04 | METHOD FOR PROLONGING THE ACTION OF DRUGS THROUGH THE FORMATION OF MCROMOLECULAR COMPOUNDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE813251A true BE813251A (en) | 1974-07-31 |
Family
ID=11198242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE142809A BE813251A (en) | 1973-04-04 | 1974-04-03 | PROCESS FOR PROLONGING THE EFFECT OF PHARMACEUTICAL COMPOUNDS |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS5035316A (en) |
| BE (1) | BE813251A (en) |
| DE (1) | DE2413512A1 (en) |
| FR (1) | FR2224164A1 (en) |
| IT (1) | IT1053718B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58152820A (en) * | 1982-03-04 | 1983-09-10 | Kyosei Seiyaku Kk | Composition for remedying cancer |
| EP0224987B1 (en) * | 1985-11-29 | 1992-04-15 | Biomatrix, Inc. | Drug delivery systems based on hyaluronan, derivatives thereof and their salts and method of producing same |
| ATE166361T1 (en) * | 1991-02-21 | 1998-06-15 | Drug Delivery System Inst Ltd | CARBOXYMETHYLMANNOGLUCAN AND DERIVATIVES THEREOF |
| FR2943538B1 (en) * | 2009-03-27 | 2011-05-20 | Adocia | QUICK ACTION FORMULATION OF RECOMBINANT HUMAN INSULIN |
| US9018190B2 (en) | 2009-03-27 | 2015-04-28 | Adocia | Functionalized oligosaccharides |
| US20130231281A1 (en) | 2011-11-02 | 2013-09-05 | Adocia | Rapid acting insulin formulation comprising an oligosaccharide |
| ES2670969T3 (en) | 2012-11-13 | 2018-06-04 | Adocia | Fast-acting insulin formulation comprising a substituted anionic compound |
| US9795678B2 (en) | 2014-05-14 | 2017-10-24 | Adocia | Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound |
| FR3020947B1 (en) | 2014-05-14 | 2018-08-31 | Adocia | AQUEOUS COMPOSITION COMPRISING AT LEAST ONE PROTEIN AND A SOLUBILIZING AGENT, ITS PREPARATION AND ITS USES |
| FR3043557B1 (en) | 2015-11-16 | 2019-05-31 | Adocia | RAPID ACID COMPOSITION OF INSULIN COMPRISING A SUBSTITUTED CITRATE |
-
1973
- 1973-04-04 IT IT22595/73A patent/IT1053718B/en active
-
1974
- 1974-03-21 DE DE2413512A patent/DE2413512A1/en active Pending
- 1974-04-02 FR FR7411676A patent/FR2224164A1/en not_active Withdrawn
- 1974-04-03 JP JP49037731A patent/JPS5035316A/ja active Pending
- 1974-04-03 BE BE142809A patent/BE813251A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5035316A (en) | 1975-04-04 |
| FR2224164A1 (en) | 1974-10-31 |
| IT1053718B (en) | 1981-10-10 |
| DE2413512A1 (en) | 1974-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE821983A (en) | PROCESS FOR THE PREPARATION OF HYDROXYCHOLESTERINS | |
| RO63965A (en) | PROCESS FOR THE PREPARATION OF PHENYLPROPIONIC ACIDS | |
| RO63761A (en) | PROCESS FOR THE PREPARATION OF 0-SUBSTITUTED-7-BETA-AMINO-3-CEPHEM-3-OLE-4-CARBOXYLIC ACID DERIVATIVES | |
| BE822990A (en) | PROCESS FOR THE PREPARATION OF HEXAMETHYLTETRALINE | |
| RO65957A (en) | PROCESS FOR THE PREPARATION OF PIPERAZINYL-QUINAZOLINES | |
| RO66825A (en) | PROCESS FOR THE PREPARATION OF TRANS-7-CIS-9-DODECADIEN-1-YL ACETATE | |
| RO63539A (en) | PROCESS FOR THE PREPARATION OF PIPERAZINYLQUINOXALINES | |
| BE812104A (en) | PROCESS FOR THE PREPARATION OF ALDEHYDES | |
| BE813251A (en) | PROCESS FOR PROLONGING THE EFFECT OF PHARMACEUTICAL COMPOUNDS | |
| RO63655A (en) | PROCESS FOR THE PREPARATION OF ISOQUINOLINE DERIVATIVES | |
| RO63749A (en) | PROCESS FOR THE PREPARATION OF 5-PYRAZOLONES-1-SUBSTITUTED | |
| RO63724A (en) | PROCESS FOR THE PREPARATION OF OXADIAZOLONE DERIVATIVES | |
| FR2303543A1 (en) | NEW PROCESS FOR THE PREPARATION OF AMOXYCILLIN | |
| BE817761A (en) | PROCESS FOR THE PREPARATION OF O-BENZYLTOLUENES | |
| RO63730A (en) | PROCESS FOR THE PREPARATION OF INDOLINE DERIVATIVES | |
| RO63035A (en) | PROCESS FOR THE PREPARATION OF 2-PHENYLAMINOIMIDAZOLINES- (2) -SUBSTITUES | |
| RO68378A (en) | PROCESS FOR THE PREPARATION OF N-BENZHIDRYL-N'-P-HYDROXYBENZYL-PIPERAZINES | |
| BE820662A (en) | PHOTOCHEMICAL PROCESS FOR THE PREPARATION OF HYDROCARBON ADDITION COMPOUNDS | |
| RO63792A (en) | PROCESS FOR THE PREPARATION OF ERGOLINES-0-6-METHYL-2-8-SUBSTITUTED | |
| RO68008A (en) | PROCESS FOR THE PREPARATION OF POLES-N-ALKYL IMINOALANES | |
| RO64595A (en) | PROCESS FOR THE PREPARATION OF 3-HALOGEN-CEPHALOSPORINS E-CEPHALO SPORINS COMPOUNDS | |
| RO63505A (en) | PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES | |
| RO62902A (en) | PROCESS FOR THE PREPARATION OF OXINDOLE DERIVATIVES | |
| BE763130A (en) | CONTINUOUS PROCESS FOR THE PREPARATION OF ALUMINUM-ALCOYL COMPOUNDS | |
| BE822618A (en) | NEW PROCESS FOR THE PREPARATION OF THE ANTIBIOTIC |